In the acute phase of colitis in trinitrobenzene-sulfonic acid (TNBS)-induced mouse model of intestinal inflammation, a decrease in the level of FAAH mRNA was observed in inflamed region of colon, while in the late phase of inflammation, the level of FAAH was increased
Labeled "for research use only, not for human consumption." No FDA oversight on manufacturing
How BPC-157 Works BPC-157 promotes rapid recovery and cellular repair by: Stimulating angiogenesis (new blood vessel formation) Enhancing collagen synthesis for stronger connective tissue Reducing inflammation and oxidative stress Regenerating intestinal lining and restoring gut-brain axis balance Improving blood flow, nitric oxide function, and tissue oxygenation Conditions Supported by BPC-157 Therapy Muscle, Tendon & Ligament Repair Muscle tears, microtears, and overuse injuries Tendonitis (Achilles, patellar, rotator cuff, biceps) Ligament injuries (ACL, MCL, meniscus) Sports injuries and post-surgical recovery Joint & Bone Regeneration Osteoarthritis and degenerative joint pain Cartilage loss and stiffness Bone fractures and delayed healing Post-reconstruction ligament rehabilitation Nerve & Pain Syndromes Peripheral nerve damage Sciatica and neuropathic pain Fibromyalgia and myofascial pain BPC-157 and Gut-Brain Axis Health BPC-157 supports the gut-brain axis the communication link between digestion and mental health by repairing the gut lining and reducing inflammation
Plus, our peptides are made in America in a cGMP Facility and have a bio-availability of up to 92%, making them a really effective alternative to injectable peptides
